-
Fangzhou Inc. Partners with Tencent Health to Advance AI-Driven Healthcare Solutions
•
Guangzhou-based smart healthcare service platform Fangzhou Inc. (HKG: 6086) has announced a strategic partnership with China Internet giant Tencent’s Tencent Health and Tencent Cloud. The alliance aims to accelerate the development and implementation of AI-driven healthcare solutions by integrating the DeepSeek open-source AI Model on Fangzhou’s platform. Partnership DetailsThrough this…
-
Fangzhou Inc. Partners with BMS to Innovate Digital Medicine Platform
•
China-based Internet healthcare solutions provider Fangzhou Inc. (HKG: 6086) has entered into a partnership with the China unit of US major Bristol-Myers Squibb (BMS, NYSE: BMY). The collaboration, with financial details undisclosed, aims to jointly develop a digital medicine platform and upgrade the Internet health management model, marking a significant…
-
Fangzhou Inc. Expands Partnerships with Tencent Healthcare and Baidu Health at Digital Summit
•
China-based Fangzhou Inc. (HKG: 6086) hosted the “Data and AI: Decoding Digital Engagement” summit in Chengdu, an event focused on the intersection of data and artificial intelligence in the digital healthcare space. During the summit, Fangzhou Inc. expanded its strategic partnerships with Tencent Healthcare and Baidu Health, two major players…
-
Jianke.com Files for Hong Kong IPO with Focus on Chronic Disease Management
•
China-based smart healthcare service platform Jianke.com (Fangzhou Inc.) has filed for an initial public offering (IPO) on the Hong Kong Stock Exchange. Citibank, UBS, and ABC International will act as co-sponsors. The filing marks a significant step in the company’s expansion plans, aiming to leverage its comprehensive healthcare services and…
